Skip to main content

Table 2 Distribution of risk attitude, socioeconomic factors, duration of treatment and comorbidity, n = 6396*

From: Associations between patients’ risk attitude and their adherence to statin treatment – a population based questionnaire and register study

 

N (%)

Risk attitude, Financial

 

 Risk-averse

5188 (81.1)

 Risk-neutral

512 (8.0)

 Risk-seeking

696 (10.9)

Risk attitude, health: Focus on healthy behaviour

 

 Risk-averse

4153 (64.9)

 Risk-neutral

1436 (22.5)

 Risk-seeking

807 (12.6)

Risk attitude, health: Count on symptoms passing

 

 Risk-averse

776 (12.1)

 Risk-neutral

591 (9.2)

 Risk-seeking

5029 (78.6)

Risk attitude, health: Preference for GP contact regarding my health

 

 Risk-averse

3572 (55.9)

 Risk-neutral

1244 (19.5)

 Risk-seeking

1580 (24.7)

Gender

 

 Male

3544 (55.4)

 Female

2852 (44.5)

Age (years)

 

 20–39

70 (1.1)

 40–59

1781 (27.9)

 60–79

4545 (71.1)

Income

 

 Low (1st quartile)

957 (15.0)

 Medium (2nd + 3rd quartile)

3504 (54.8)

 High (4th quartile)

1933 (30.2)

Highest attained educational level (years)

 

  < 10

1757 (27.9)

 10–12

2992 (47.5)

  > 12

1551 (24.6)

Cohabitation status

 

 Single

1399 (21.9)

 Married/cohabiting

4995 (78.1)

Labour market status

 

 Working

2574 (40.2)

 Retirement pension

3193 (49.9)

 Not in the workforce

629 (9.8)

Duration of statin treatment

 

  < 1 year

539 (8.4)

 1–2 years

547 (8.6)

 2–5 years

3089 (48.3)

 5–10 years

1526 (23.9)

  < 10 years

695 (10.9)

Comorbidity

 

 CVD

 

 No CVD

5340 (83.5)

 CVD

1056 (16.5)

Charlson

 

 None

3593 (55.6)

 1

1491 (23.8)

  ≥ 2

1289 (20.6)

  1. *Up to 1.5 % missings in registers